Diagnosis and treatment of congenital hemophilia with inhibitors. A Latin American perspective

The Committee of Latin America on the Therapeutics of Inhibitor Groups (CLOTTING) is composed of a number of hemophilia specialists from Latin America. The group aims to encourage the adoption of a good standard of care for Latin American patients with hemophilia. The occurrence of inhibitors in patients with hemophilia poses clinical challenges, and it is estimated that between 1000 and 3 000 patients in Latin America are affected by hemophilia with inhibitors. There is an urgent need to establish a regional consensus and clinical guidelines for the diagnosis and treatment of these patients. We present an extensive review based on best current clinical practice and published literature, as seen from a Latin American perspective, taking into account the variable nature of hemophilia care available in the various countries in this Region.

• Autores: Pérez Bianco, Raúl; Castro Ozelo, Margareth; Ribeiro Villaça, Paula; Helena Solano, María; Jiménez Cruz, Guillermo; Martinez Murillo, Carlos; García Chavez, Jaime; Mendoza, Saul; Rodríguez Grecco, Ismael; Ruiz Saez, Arlette
• Tipo de recurso: Article of journal
• Fecha de publicación: 2008
• Institución: Fundación Universitaria de Ciencias de la Salud - FUCS
• Repositorio: Repositorio Digital Institucional ReDi
• Idioma: eng
• OAI Identifier: oai:repositorio.fucsalud.edu.co:001/1489
• Acceso en línea: https://repositorio.fucsalud.edu.co/handle/001/1489
• Palabra clave: Hemophilia; Inhibitors; Treatment; Hemophilia guidelines; Hemofilia A; Hemofilia B
• Rights: openAccess
• License: Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)